Annual Total Debt
$41.20 M
+$1.00 M+2.50%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual total debt is $41.20 million, with the most recent change of +$1.00 million (+2.50%) on December 31, 2023.
- During the last 3 years, EIGR annual total debt has risen by +$8.69 million (+26.72%).
- EIGR annual total debt is now at all-time high.
Performance
EIGR Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$41.20 M
+$264.00 K+0.64%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly total debt is $41.20 million, with the most recent change of +$264.00 thousand (+0.64%) on December 31, 2023.
- Over the past year, EIGR quarterly total debt has increased by +$1.00 million (+2.50%).
- EIGR quarterly total debt is now at all-time high.
Performance
EIGR Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
EIGR Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.5% | +2.5% |
| 3 y3 years | +26.7% | +26.7% |
| 5 y5 years | +60.8% | +60.8% |
EIGR Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.6% | at high | +26.6% |
| 5 y | 5-year | at high | +27.8% | at high | +27.8% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Eiger BioPharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $41.20 M(+2.5%) | $41.20 M(+0.6%) |
| Sep 2023 | - | $40.94 M(+0.7%) |
| Jun 2023 | - | $40.67 M(+0.6%) |
| Mar 2023 | - | $40.42 M(+0.6%) |
| Dec 2022 | $40.20 M(+23.5%) | $40.20 M(+1.5%) |
| Sep 2022 | - | $39.59 M(+0.6%) |
| Jun 2022 | - | $39.35 M(+20.8%) |
| Mar 2022 | - | $32.59 M(+0.2%) |
| Dec 2021 | $32.54 M(+0.1%) | $32.54 M(+0.2%) |
| Sep 2021 | - | $32.48 M(+0.2%) |
| Jun 2021 | - | $32.43 M(+0.1%) |
| Mar 2021 | - | $32.41 M(-0.3%) |
| Dec 2020 | $32.51 M(+0.8%) | $32.51 M(+0.3%) |
| Sep 2020 | - | $32.43 M(+0.3%) |
| Jun 2020 | - | $32.35 M(+0.1%) |
| Mar 2020 | - | $32.32 M(+0.2%) |
| Dec 2019 | $32.24 M(+25.9%) | $32.24 M(+0.6%) |
| Sep 2019 | - | $32.06 M(+0.2%) |
| Jun 2019 | - | $31.98 M(+0.2%) |
| Mar 2019 | - | $31.91 M(+24.6%) |
| Dec 2018 | $25.62 M | $25.62 M(+0.8%) |
| Sep 2018 | - | $25.42 M(+25.4%) |
| Jun 2018 | - | $20.27 M(+33.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $15.19 M(+0.6%) |
| Dec 2017 | $15.09 M(+2.5%) | $15.09 M(+0.7%) |
| Sep 2017 | - | $14.99 M(+0.6%) |
| Jun 2017 | - | $14.90 M(+0.7%) |
| Mar 2017 | - | $14.80 M(+0.5%) |
| Dec 2016 | $14.73 M(>+9900.0%) | $14.73 M(>+9900.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(-100.0%) |
| Jun 2015 | - | $10.60 M(+2.1%) |
| Mar 2015 | - | $10.38 M(+2.8%) |
| Dec 2014 | $10.10 M(+867.7%) | $10.10 M(+1.9%) |
| Sep 2014 | - | $9.91 M(>+9900.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(-100.0%) |
| Dec 2013 | $1.04 M(>+9900.0%) | $1.04 M(>+9900.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00 |
| Dec 2012 | $0.00(-100.0%) | - |
| Dec 2011 | $12.35 M(>+9900.0%) | - |
| Jun 2011 | $0.00 | - |
FAQ
- What is Eiger BioPharmaceuticals annual total debt?
- What is the all time high annual total debt for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual total debt year-on-year change?
- What is Eiger BioPharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly total debt year-on-year change?
What is Eiger BioPharmaceuticals annual total debt?
The current annual total debt of EIGR is $41.20 M
What is the all time high annual total debt for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual total debt is $41.20 M
What is Eiger BioPharmaceuticals annual total debt year-on-year change?
Over the past year, EIGR annual total debt has changed by +$1.00 M (+2.50%)
What is Eiger BioPharmaceuticals quarterly total debt?
The current quarterly total debt of EIGR is $41.20 M
What is the all time high quarterly total debt for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly total debt is $41.20 M
What is Eiger BioPharmaceuticals quarterly total debt year-on-year change?
Over the past year, EIGR quarterly total debt has changed by +$1.00 M (+2.50%)